Ima, INC.
550 S Landmark Ave, Bloomington, IN 47403
Source: CMS National Provider Identifier registry Source: CMS NPI registry Data updated July 2026
321 NPI‑verified weight loss and GLP‑1 providers across 61 Indiana cities — every listing sourced from the federal provider registry.
Indiana has 321 providers registered with the federal government under an obesity medicine, bariatric medicine, or endocrinology specialty, spread across 61 cities. Indianapolis has the most, with 96. Registry listing confirms a provider's specialty, not that they currently prescribe semaglutide or tirzepatide.
Shown in source-data order. We do not rank, rate, or feature providers — pick a city above to see every listing in your area.
550 S Landmark Ave, Bloomington, IN 47403
550 S Landmark Ave, Bloomington, IN 47403
12337 Hancock St Ste 18, Carmel, IN 46032
11911 N Meridian St Ste 125, Carmel, IN 46032
11805 N Pennsylvania St, Carmel, IN 46032
1260 City Center Dr, Carmel, IN 46032
The CMS NPI registry lists 321 weight loss, obesity medicine, bariatric, and endocrinology providers in Indiana, across 61 cities. Indianapolis has the most, with 96 listed providers.
Yes. Telehealth GLP-1 treatment is available to Indiana residents. An online visit with a licensed provider can result in a prescription for semaglutide or tirzepatide when medically appropriate, with medication shipped to your door.
Most clinics evaluate patients for semaglutide and tirzepatide. Availability, pricing, and whether a clinic dispenses an FDA-approved brand-name product or a compounded preparation all vary by practice. Compounded drugs are prepared by a state-licensed compounding pharmacy; they are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Call ahead to confirm what a practice offers.